Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Clinical trial NCT01532453 · TERMINATED

Trial details

NCT number: NCT01532453
Sponsor: Spirig Pharma Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratoses Squamous Cell Carcinomas

Start date: 2010-11-01
Primary completion: 2014-01-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.